PFE · Pfizer
Latest news, signals, and AI analysis for Pfizer (PFE) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent PFE News
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Pfizer Inks Up to $10.5 Billion Deal With China’s Innovent - Bloomberg.com
Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom - Reuters
Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing
UBS maintains Pfizer stock rating ahead of cancer drug trial results
BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results
Related Tickers
$JNJ · Johnson & Johnson$LLY · Eli Lilly$MRK · Merck$ABBV · AbbVie$NVO · Novo Nordisk$GILD · Gilead SciencesFrequently Asked Questions
What sector does PFE belong to?
PFE (Pfizer) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time PFE news?
Catalayer aggregates PFE coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/PFE.
How fast are PFE news alerts on Catalayer?
News is polled every 30–60 seconds. PFE-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for PFE?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every PFE story.
Is PFE covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support PFE. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.